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KAJIAN FARMAKOLOGI TERPILIH EKSTRAK METANOL DAUN 
Cinnamomum iners TERPIAWAI 
 
ABSTRAK 
Penyaringan fitokimia, antioksida, kajian ketoksikan, aktiviti analgesik dan 
antimikrob telah dijalankan ke atas ekstrak daun metanol Cinnamomum iners yang 
telah dipiawaikan (CSLE). Penyaringan fitokimia menunjukkan kehadiran glikosida 
kardia, flavonoid, fenolik, saponin, tannin dan terpenoid. Kehadiran metabolit 
sekunder ini di dalam CSLE mungkin penyumbang  kepada bioaktiviti CSLE.  
Secara keseluruhannya, kajian antioksida mendapati CSLE menunjukkan aktiviti 
antioksida yang sederhana baik. Aktiviti antioksida ini mungkin disebabkan oleh 
kandungan fenolik yang tinggi di dalam CSLE (211.94 ± 13.04 ekivalen mg asid 
gallik/g jisim tumbuhan). Penyelidikan juga telah dijalankan bagi menentukan 
ketoksikan CSLE memandangkan tumbuhan ini telah digunakan sejak lama dahulu 
sebagai herba tradisi. Penyaringan ketoksikan CSLE dijalankan menggunakan  ujian 
anak udang brin, ketoksikan akut dan histopatologi. Ujian ketoksikan akut dijalankan 
berpandukan arahan OECD 423 (Organisasi Kerjasama dan Pembangunan 
Ekonomi). Ujian ketoksikan mendapati CSLE selamat digunakan dengan nilai LD50 
dan LC50 yang tinggi. Penyaringan aktiviti analgesik CSLE dijalankan menggunakan 
ujian formalin, plat panas dan jentik ekor pada dos 100, 200 dan 500 mg/kg pada 
mencit. CSLE menunjukkan aktiviti yang signifikan (P<0.05) pada tikus bagi fasa 
terakhir ujian formalin pada dos 200 dan 500 mg/kg. Walaubagaimanapun, CSLE 
tidak menunjukkan sebarang aktiviti bagi ujian plat panas dan jentik ekor. Kajian ini 
menunjukkan bahawa CSLE bertindak pada sistem saraf periferi bagi melegakan 
sakit. Bagi penyaringan aktiviti antimikrob, CSLE, fraksi (heksana, etil asetat, 
butanol dan akueus) dan sebatian bioaktif yang telah dipencilkan diuji menggunakan 
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kaedah yang berbeza beza. Kaedah pembauran cakera, nilai perencatan minimum 
(MIC) dan nilai kepekatan maut minimum (MBC) telah ditentukan bagi CSLE dan 
fraksi menggunakan bakteria gram positif, gram negatif dan yis.  Kajian lanjut bagi 
mengenalpasti sebatian antimikrob dijalankan menggunakan teknik bioautografi. 
Kedah bioautografi menunjukkan kehadiran satu sebatian dari fraksi etil asetat (nilai 
Rf 0.77) yang merencat pertumbuhan MRSA (Staphylococcus aureus rintang 
metisillin). Sebatian yang sama juga didapati merencat pertumbuhan Escherichia 
coli. Sebatian tersebut telah berjaya dipencilkan dan dikenalpasti meggunakan 
spektroskopi ultralembayung, inframerah, spektroskopi 
1
H dan 
13
C resonans magnet 
nukleus dan spektroskopi jisim. Sebatian bioaktif tersebut dikenalpasti sebagai 
xanthorrhizol 2-methyl-5-[(2R)-6-methylhept-5-en-2-yl] phenol. Secara 
keseluruhannya, keputusan kajian ini mendapati daun Cinnamomum iners dan 
sebatian yang dipencilkan (xanthorrhizol) berpotensi sebagai sumber ubatan 
antimikrob yang baru bagi MRSA dan juga mikroorganisma patogen yang lain.  
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SELECTED PHARMACOLOGICAL STUDIES OF Cinnamomum iners 
STANDARDIZED LEAVES METHANOLIC EXTRACT 
 
ABSTRACT 
 
Cinnamomum iners standardized leaves methanolic extract (CSLE) was 
subjected to phytochemical screening, antioxidant, toxicity studies, analgesic and 
antimicrobial activity. Phytochemical screening of CSLE showed the presence of 
cardiac glycoside, flavanoid, polyphenol, saponin, tannin and terpenoid. These 
secondary metabolites might be contributed to the bioactivity of CSLE. The overall 
antioxidant research provides information that CSLE showed moderate antioxidant 
activity. This might be due to the high phenolic content (211.94 ± 13.04 mg GAE/g 
plant material) in CSLE. Our study also investigated the safety parameters (toxicity) 
of CSLE to provide information regarding long term usage of this plant as traditional 
herbs. The toxicity screening of CSLE was conducted using brine shrimp assay, 
acute toxicity screening and histopathologic study. An acute toxicity study was 
carried out using OECD (The organization of Economic Co-operation Development) 
guideline 423. CSLE is considered safe for consumption with high LC50 and LD50 
values. The analgesic activity of CSLE was evaluated using formalin, hot plate and 
tail flick tests at doses of 100, 200 and 500 mg/kg in mice. CSLE showed significant 
activity (P<0.05) in the formalin model (late phase) on the rats at 200 and 500 
mg/kg. However, CSLE did not show activity in the hot plate and tail flick test. The 
results obtained suggest that CSLE act peripherally to relieve pain. As for the 
antimicrobial activity, CSLE, its fractions (hexane, ethyl acetate, butanol and 
aqueous) and the isolated compound of CSLE was investigated using different 
antimicrobial assays. CSLE and fractions were subjected to disc diffusion test, 
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minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC) using different gram positive, gram negative and yeast. Subsequent work was 
focused on the identification of antimicrobial compound by the means of 
bioautography. Bioautography assay of fractions revealed one compound of ethyl 
acetate fraction (Rf of 0.77) inhibited MRSA (methicillin resistant Staphylococcus 
aureus). Interestingly the same compound was found to inhibit Escherichia coli. The 
compound was successfully isolated and the isolated compound was identified by 
using ultraviolet, infrared, 
1
H and 
13
C nuclear magnetic resonance spectroscopy and 
mass spectroscopy. The compound was recognized as xanthorrhizol 2-methyl-5-
[(2R)-6-methylhept-5-en-2-yl] phenol. The overall results provide evidence that 
Cinnamomum iners leaves as well as the isolated compound (xanthorrhizol) 
exhibited potential as new antimicrobial drug for MRSA as well as other pathogenic 
microorganisms
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CHAPTER 1 
INTRODUCTION 
Cinnamomum iners leaves are widely practised as traditional medicine for 
various ailments such as fever, headache, breathing problem and cough. In addition, 
Cinnamomum iners leaves are used to treat problem related to digestive system and 
appetite. Even though this plant has been used for a long time, there is a lack of 
scientific data regarding this plant. Therefore, scientific data need to be built up to 
document the potential of this herb. In this context, this work was undertaken to 
determine the antioxidant capacity, analgesic effect and antimicrobial activity of 
Cinnamomum iners standardized leaves methanolic extract (CSLE). In addition, the 
safety parameter of CSLE was determined to provide information regarding the long 
term usage of this plant. The secondary metabolite presence in CSLE was also 
identified using phytochemical screening procedure. 
The antioxidant activity of CSLE was evaluated using scavenging activity 
and reducing power assay. The analgesic effect of CSLE was investigated using hot 
plate, tail flick and formalin test. As for the antimicrobial activity, CSLE was 
subjected to disc diffusion test, minimum inhibitory concentration (MIC) and 
minimum bactericidal concentration (MBC) using different gram positive, gram 
negative and yeast. The findings of the overall research study have provided an 
insight into the bioactivity of CSLE. This study also has provided scientific evidence 
to prove the traditional claim of Cinnamomum iners leaves against various diseases. 
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RESEARCH OBJECTIVES 
The objectives of the research are listed as follows: 
a) To standardize extract of Cinnamomum iners leaves by using marker 
compound. 
b) To determine the toxicity of Cinnamomum iners standardized leaves 
methanolic extract by using brine shrimp and acute toxicity studies. 
c) To determine the antioxidant activity of Cinnamomum iners standardized 
leaves methanolic extract. 
d) To determine the analgesic effect of Cinnamomum iners standardized leaves 
methanolic extract. 
e) To determine the antimicrobial properties of Cinnamomum iners standardized  
leaves methanolic extract. 
f) To identify the bioactive compound from Cinnamomum iners standardized 
leaves methanolic extract. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Discovery of Plant- Derived Drugs 
2.1.1 Definition, History and Examples of Plant-Derived Drugs 
Plants are extremely important matter of our planet which is essential to 
maintain the balance of nature and plays vital role in human life as they provide us 
with food, medicine, oxygen, clothing and shelter.  Furthermore, medicinal plant is 
the source of drug which is rich in therapeutic values (Edeoga et al., 2005). The 
World Health Organization (WHO) estimated that 70 to 80% of the developing 
countries implemented traditional medicine mainly from herbs as the alternative 
medicine.  Medicinal plants have high economic impact to the world and are widely 
used by large majority of population to cure disease and illness (Bauman, 2004). The 
plant extracts and their constituents play major role in traditional medicines and 
therapies (Willet, 1994). Pang et al. (2000) reported that traditional herbal medicine 
is considered as an art of healing. The pharmacological activity of herbal medicine is 
contributed by the specific biologically active compounds and also the synergistic 
effect of plant extract. Synergistic effect results from the combination of two or more 
chemical components present in the herbal mixture (Pang et al., 2000).  
Ethno pharmacological documentation on the safety of locally used herbal 
plants can lead to the development of new herbal drugs (Cowan, 1999). There is now 
much scientific activity on the use of plants by cultural groups (ethnopharmacology) 
since it is realized that much knowledge is being lost due to the breakdown of many 
traditional societies due to urbanization (Raman and Houghton, 1998). The term of 
plant derived drugs can be defined as isolation of substances from plant that possess 
biological activity. Based on the statistical analysis, approximately 119 pure 
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compounds isolated from plants are used as medicine throughout the world such as 
aspirin, quinine and morphine (Farnsworth and Pezzuto, 1983).  
Acetylsalicylic acid or commonly known as aspirin is derived from Salix alba 
(white willow). Aspirin which is consumed by 80 million people in US alone is 
widely practice as medication to relieve pains, inflammation and reduce fever. In 
addition, aspirin is extremely useful as an anti-platelet agent to prevent heart attacks 
and strokes.  Another good example of plant based drug is quinine. Quinine which 
originated from Cinchona ledgeriana bark is very useful for the treatment of malaria 
(Farnsworth and Pezzuto, 1983). Serpentine isolated from the root of the Indian plant 
Rauwolfia serpentina was an outstanding contribution for lowering blood pressure 
and treatment of hypertension (Farnsworth et al., 1967). Vinblastine isolated from 
the Catharanthus roseus is used for neck cancer and leukemia in children. 
Pophyllotoxin derived from Phodophyllum emodi was used for treatment against 
testicular, small cell lung cancer and lymphomas (Farnsworth and Bingel, 1977). The 
chemotherapy drug paclitaxel (Taxol), used in breast, ovarian and lung cancer 
treatment, is derived from Taxus brevifolia (Farnsworth and Bingel, 1977). Between 
1971 to 1990 new drugs such as ectoposide, E-guggulsterone, teniposide, nabilone, 
plaunotol and ginkgolides continue to be introduced all over the world.  
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Table 2.1: Examples of plant-derived drugs 
Drugs       Properties Plant 
 
Borneol Antipyretic, analgesic, 
antiinflammatory 
Several plants such as 
Dryobalanops aromatic 
and Blumea balsamifera 
Codeine 
Ectoposide 
E-guggulsterone 
Analgesic, antitussive 
Anticancer 
Antidiabetic 
Papaver somniferum  
Podophyllum peltatum 
Commiphora weightii 
Morphine Analgesic Papaver somniferum  
Nordihydroguaiaretic acid 
Pophyllotoxin 
Quinine 
Antioxidant 
Anticancer 
Antimalaria 
Larrea divaricata  
Phodophyllum emodi 
Cinchona ledgeriana 
Rotundine Analgesic, sedative, 
tranquilizer 
Stephania sinica 
Salicin 
Serpentine 
Taxol 
Analgesic 
Antiinflammatory 
Analgesic 
Salix alba  
Rauwolfia serpentina 
Taxus brevifolia 
Tetrahydropalmatine 
 
Vinblastine 
Analgesic, sedative, 
tranquilizer 
Anticancer 
 
Corydalis ambigua 
 
Catharanthus roseus 
(Farnsworth and Bingel, 1977) 
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2.1.2 Importance of Drugs Discovery from Plants 
In recent times, the development of synthetic drug is gaining attention from 
scientist worldwide. Synthetic drugs refer to bioactive substance of plant that is being 
derived from chemical process (not originated from plants) (Verpoorte, 2000). 
However, synthesizing some of the plant derived drug such as morphine and cocaine 
remains a challenge for researchers. Some drugs cannot be synthetically produced 
such as atropine and reserpine due to high costs (Rahman et al., 2005). Hence, the 
isolation of plants derived drugs is a key determinant in drug discovery. 
2.2 Selection of Plant for Drug Discovery 
The estimated higher plant species that exist on this earth is 250 thousands. 
From this number, only about 15 thousands have been evaluated for their biological 
activity (Verpoorte, 2000). Realizing the fact that undiscovered plants might have 
some therapeutic value, many researchers have focused on discovering potential 
plant sources with medicinal properties. However, there are some broad starting 
points of selecting plant material of interest. Several reviews had proposed method 
for selecting plants of choice as the subject of research. Phytochemical screening is a 
commonly used method by the developing countries which employs random 
selection of plant materials followed by chemical screening for the identification of 
bioactive compounds (Farnsworth, 1966). Second approaches are random selection 
followed by biological assessment of the plants. Biological activity was evaluated by 
means of experimental animals such as mice and rats (Suffness and Douros, 1982). 
Plants of interest might also be selected based on the traditional claims for the 
treatment of diseases (Bannerman et al., 1983). These plants have ethnobotanical 
background which is related to ancient people natural remedies. Example of plant 
that was selected based on the ethnobotanical background is turmeric (Curcuma 
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longa) that has been practised in Indian Ayurveda for various ailments. Based on the 
traditional claim that turmeric exhibit antimicrobial activity, several studies was 
conducted and lead to the discovery of curcumin (Aggarwal et al., 2005).  
2.3 Cinnamomum iners 
2.3.1 Morphological description 
Cinnamomum iners is a genus of evergreen trees and shrubs belonging to the 
family, Lauraceae. According to the Agroforestry Tree Database, Cinnamomum iners 
is commonly found in India, Burma (Myanmar), Indo-China, Thailand, Peninsular 
Malaysia, Sumatra, Java, Borneo, Sulawesi and the Southern Philippines. It is a 
medium-sized evergreen tree found throughout lowland and hill forest of Malaysia. It 
is locally known as kayu manis hutan, medang kemangi and teja.  
Usual appearances of Cinnamomum iners is about 60 feet height with dense, 
bushy and dull green in colour. The leaves are arranged either opposite or nearly 
opposite with three main longitudinal veins, 7.5-30 cm long, 2-13 cm wide (Choi et 
al., 2003). Flowers are very small, creamy white or yellowish in long stalked 
panicles. Fruit is round, blue black in colour when ripening. The bark is greyish 
brown in colour, rather smooth and even (Corner, 1952). 
Taxonomy of Cinnamomum iners 
Kingdom : Plantae 
Division : Magniliophyta 
Class : Magnoliopsida 
Order : Laurale  
Family : Lauraceae 
Genus : Cinnamomum  
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Species : Iners 
 
       Figure 2.1: Leaves of Cinnamomum iners    Figure 2.2: Tree of Cinnamomum iners 
 
2.3.2 Bioactivity Studies of Cinnamomum iners 
Although Cinnamomum iners is widely cultivated and practised medicinally, 
the information on its biological properties is still limited. Due to the presence of 
terpenes, it is widely used as traditional medicine to relieve fever, for digestive 
system and appetite problem (Pengelly, 2004). In addition, this plant leaves have 
been used for rheumatism, headache, breathing problem and cough. The major 
bioactive compounds of this plant leaves are saponin, terpene, cinnamic aldehyde 
and eugenol (Choi et al., 2003). Based on the traditional claim, several studies had 
been carried out to prove this claim scientifically. Researchers from India reported 
that oil obtained from stem bark of Cinnamomum iners contain 1, 8-cineole as a 
major component that possess antinociceptive and anti-inflammatory activity 
(Baruah et al., 2001). The antioxidant activity of essential oil of Cinnamomum iners 
has also been reported (Phutdhawong et al., 2007). Recently, the analgesic properties 
of this plant leaves have been published by our research team (Mustaffa et al., 
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2010a). The antioxidant activity and toxicity of this plant was recently reported by 
our research team (Mustaffa et al., 2010b). The ethnobotanical reports offer 
information on the medicinal properties of Cinnamomum iners root extract that 
include details on their antiplasmodial activity and cytotoxicity (Wan et al., 2007). 
Furthermore, an amylase inhibitory property of this plant has been revealed (Iida et 
al., 1997).  
2.4 Plant Secondary Metabolites 
2.4.1 Definition of Plant Secondary Metabolites 
 Most of the available medicines are derived of plants, it shows that they 
contain organic compounds with pharmacological activities that can act as 
pharmaceutical drugs.  Plant organic compounds are synthesized from complex 
metabolism processes. The biosynthetic pathways are universal in plants and are 
responsible for the occurrence of both primary metabolites and secondary 
metabolites. Primary plant metabolites are directly involved in the growth, 
reproduction and development of the plant itself.  Secondary metabolites are not 
directly involved in those processes but are classified as organic compounds that are 
biologically active (Chakraborty and Brantner, 1999). Examples of plant secondary 
metabolites are alkaloids, terpenoids, tannins and steroids. In fact there are numerous 
studies which have revealed the presence of such compounds with antimicrobial, 
antioxidant and analgesic activities (Arima and Danno, 2002). Terpenoids consist of 
important groups of active compounds with over 20 000 known structures. Examples 
are gossypol, parthenolide and artemisinin. Gossypol was derived from Gossypium 
herbaceum and used as an antifertility agent in human (Huang, 1993). Parthenolide 
from feverfew (Tanacetum parthenium) has been used for the treatment of migraine, 
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while artemisinin from Artemisia annua is widely used for malaria (Beekman et al., 
1998).  
Table 2.2: Examples of secondary metabolites from plants and its pharmacological       
                 activities 
Plants Secondary metabolites Pharmacological activities 
Andrographis paniculata Diterpenoid, flavonoids, 
polyphenol 
Anticancer, anti-
inflammatory, 
hepatoprotective, anti-
hyperglycaemic  
Curcuma xanthorrhizol Sesquiterpenoid Antibacterial, 
antiinflammatory 
Cyanara scolymus Polyphenol Hepatoprotective 
Eurycoma longifolia Triterpene, saponin Antimalaria, 
antibacterial, antioxidant, 
treatment of impotence  
Ficus deltoidea Polyphenol,  flavonoid, 
tannin 
Antidiabetic, 
antinociceptive, 
antioxidant 
Garcinia mangostana Polyphenol, tannin Antioxidant, antitumoral, 
anti-inflammatory, 
antiallergy, 
antibacterial, antimalarial 
Morinda citrofolia Alkaloid, flavonoid Anticancer, antitumour, 
antinociceptive, 
antihypertension 
Orthosiphon stamineus Flavonoid, polyphenol Antidiabetic 
Punica grantum Polyphenol Antioxidant, 
antinociceptive 
                     (Arima and Danno, 2002) 
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2.4.2 Plant Secondary Metabolism Pathways 
Recent studies continue to describe some of the secondary metabolic 
pathways leading to active phytochemicals. The pentose phosphate pathway (PPP) is 
important in the sense that it produces reducing equivalents in the form of NADPH 
which is used in the synthesizing substances such as nucleic acids and protein. PPP 
also produces erythrose-4-phosphate (E4P), used in the synthesis of aromatic amino 
acids. The aromatic amino acids are converted into phenolic compound via shikimic 
acid pathway (Ruhland, 1958). 
The shikimic acid pathway, regarded as the important biosynthetic pathway is 
the reaction between phosphoenol pyruvate (PEP) and erythrose-4-phosphate (E-4P) 
to yield phenylalanine-related alkaloids, polyphenol such as flavonoids and 
condensed tannins (Street and Cockburn, 1972) (Figure 1.3). The shikimic acid 
pathway also converts simple carbohydrate precursors derived from glycolysis and 
the pentose phosphate pathway to the aromatic amino acids (Herrmann and Weaver, 
1999). The 1-deoxy-d-xylulose 5-phosphate (DXP) pathway is responsible for the 
formation of essential oil monoterpenes (such as menthol in peppermint), 
sesquiterpenes, diterpenes, carotenoids and polyphenol. The mevalonate pathway 
operating in the cytosol gives rise to triterpenes, sterols and most sesquiterpenes 
(Ruhland, 1958). 
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Figure 2.3: Plant secondary metabolites pathway 
              (Street and Cockburn, 1972) 
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2.5 Standardization and Isolation of Plant Compounds 
Approximately 80% of people living in developing countries still rely on 
herbal plant for their health care (Verma and Singh, 2008). However, the quality 
control of herbal medicine remains to be a difficult task because of the variability of 
active constituents involved (Lijuan et al., 2007). Hence, WHO has approved 
fingerprint technique to obtain standardized herbal extract for quality assurance 
purposes which results in the consumer confidence (WHO, 1991). Standardized 
extract which identified one or two classes of bioactive compounds is the basis for 
herbal product development (Heinrich, 2007). Quality control of herbal medicines by 
the means of chromatography has become the common technique because of its 
consistency. It served as a technique for identification and authentication of herbal 
drugs which will then assured the quality control of these drugs (Gong et al., 2003). 
Various standardization procedures using thin layer chromatography, gas 
chromatography and high performance liquid chromatography are widely applied for 
this purposes. 
Standardization or chemical fingerprint represents a chromatographic pattern 
which can demonstrate both ―sameness‖ and ―differences‖ among various batches of 
sample based on the quantity of the marker compounds (Pang et al., 2000). 
Standardization as well as isolation of plant compounds is a key determinant in 
development of herbal medicines. 
Recently investigators have focused on isolation and characterization of 
plant-derived compound without regards to bioactivities. For the identification of 
novel compound from plant, bioassays must be carried out. The sequence of 
identification of bioactive compound begins with screening of extracts for biological 
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activity, followed by fractionations directed bioassays and identification of active 
substances (Mc Laughlin, 1998).  
2.6 Antioxidant Activity 
Cancer is the leading cause of death in United States. Similarly, in Malaysia, 
around 70 thousand of cancer cases were diagnosed among Malaysians between 
2000 to 2005 (Wu et al., 2005). Around 32% of death caused by cancer could be 
avoided by the intake of antioxidant rich food source (Willet, 1994; Chen et al., 
2006; Haliwell and Gutteridge, 1999). Several studies had proven that cancer and 
other diseases such as coronary heart diseases, artherosclerosis and aging is related to 
reactive oxygen species (ROS).  Examples of ROS are superoxide radical (O
.●-
 2), 
hydroxyl radicals (OH
●
) and peroxyl radicals (ROO
●
). These free radicals are being 
derived from the normal respiration processes (Madhavi et al., 1996). Exogenous 
factors such as pollution may also contribute to the formation of the free radicals 
(Subashree et al., 2009). Free radicals consist of unpaired electron which causes them 
to be chemically reactive. These chemically reactive radicals will interact with other 
molecules such as DNA, lipid and protein and will lead to oxidative damage to those 
molecules (Cadenas and Davies, 2000). Minimizing oxidative damage is the essential 
step in the prevention of ROS associated diseases. Human body had developed 
defence system to completely remove ROS by the means of enzymes such as 
gluthatione S-transferase, glutathione peroxidise, superoxide dismutase and catalase 
(Diplock, 1994). However, the imbalance between free radicals and antioxidants will 
lead to oxidative stress, resulting in protein damage and lipid peroxidation.  
Lipid peroxidation also may occur in food and cause food spoilage which 
contributes to decrease in food quality. Lipid peroxidation of food is an alarming 
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issue since it affects both the consumer and producer due to the rancid odours and 
flavours which it creates. As a solution, synthetic antioxidant such as butylated 
hydroxytoluene (BHT), butylated hydroxyanisole (BHA) and tert-butyhydro-quinone 
(TBHQ) are widely employed in food industry to combat lipid peroxidation. 
However, scientific results have proven that BHA and BHT can cause liver damage 
and carcinogenesis (Ito et al., 1986 and Whysner et al, 1994). So as an alternative a 
large body of research had focused on medicinal plants as alternatives for antioxidant 
source.  
Natural antioxidants present in the plants are closely linked to their ability to 
combat reactive oxygen species. Since ancient time people has been using various plants 
which possess antioxidant properties as medicines. Antioxidants act as "free radical 
scavengers" and hence prevent and repair damage done by these free radicals. 
Antioxidants may also enhance immune defence system, thus reducing the risk of cancer 
and infection (Kumaran and Karunakaran, 2007 and Wu et al., 2005). Moreover, it has 
been revealed that the antioxidant potential of plant products against various diseases is 
mainly due to the presence of phenolic compounds such as phenolic diterpenes, phenolic 
acids and flavonoids (Chua et al., 2008 and Atmani et al., 2009). Therefore, many 
researchers have focused on screening, characterization and isolation of potent 
polyphenolic compounds. As these compounds are predominantly present in plant and 
serve as indicators for antioxidant capacity, it is therefore worthwhile to quantify the 
phenolic content in the plant material (Mokbel and Hashinaga, 2005). Hence, antioxidant 
assays are widely used for assessing medicinal properties of plant material (Ozsoy et al., 
2008). Some general assay for evaluating the antioxidant capacity of plant material or 
pure compound include DPPH (2,2-diphenyl -1-picrylhydrazyl), reducing power, H2O2 
(hydrogen peroxide), ESR (Electron Spin Resonance), ORAC (Oxygen Radical 
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Absorbance Capacity) and ABTS [2,2-azinobis (3-ethyl-benzothiazoline-6-sulphonate)] 
(Scherer and Godoy, 2009).  
2.7 Toxicity 
Plants commonly used in traditional medicine are assumed to be safe as they 
are formed naturally. This safety is also based on their long history of usage in the 
treatment of diseases over centuries. However, scientific evidence has shown that 
many traditional herbs are toxic and can lead to cancer (Schimmer et al., 1988). For 
example, mushroom and stone fruit have been documented by Fenton (2002) for its 
toxicity and presence of potential toxins that cause death. Toxicology studies 
contributed greatly in the area of therapeutic research yet the information regarding 
toxicity of traditionally used plant is very limited. Furthermore, the prescription and 
use of traditional medicine is currently not regulated, with the result that there is 
always the danger of misadministration, especially of toxic plants. The prolonged use 
of certain popular herbal remedies may contribute to the potential genotoxic effects, 
hence toxicity study is required (Maiga et al., 2005 and Schimmer at al., 1988). 
Several reviews reported that for every 10 000 newly synthesize bioactive 
compound in US, 20 will be evaluated for the in vivo toxicity and out of this figure 
only 10 will reach for the clinical studies (Vagelos, 1991). This suggests that some 
bioactive compounds are toxic and demand toxicity studies before further 
development. Thus, brine shrimp lethality bioassay that does not require too much 
specialization and is cheap can be used as alternative for preliminary toxicity 
screening. Brine shrimp assay enables to determine the value of medium lethal 
concentration (LC50) for the active compounds presence in the extract in 24 hours 
(Massele and Nshimo, 1995). Haecke and Persoone (1982) have proposed this 
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bioassay as a standard test for toxicity assessment of natural toxins in environment 
and plant extracts. A simple zoologic organism that has been used for this purpose is 
brine shrimp or scientifically known as Artemia salina (Mc Laughlin et al., 1998). 
The first approach on the use of brine shrimp for the toxicity evaluation was reported 
in 1956. Since then researchers have widely used this animal for laboratory purposes 
(Michael et al., 1956). Furthermore, the simplicity of this method had established this 
bioassay as a general preliminary toxicity screening for plant extracts (Sam, 1993).     
Another routinely performed method for monitoring toxicity of bioactive 
plant product is by the determination of LD50 (the dose which is lethal to 50% of the 
experimental animals). LD50 serves as the basis for further development of certain 
drugs. LD50 value has been assessed by using subchronic, chronic and acute oral 
toxicity studies. Subchronic and chronic toxicity studies involved repeated 
administration of tested substances and observation period of 28 days and three 
months respectively.  In contrast, acute oral toxicity is the short term toxicity studies 
in 14 days after single administration of tested substances (Akhila et al., 2007). 
Acute oral toxicity studies are used as references for selecting starting doses for other 
animal work studies. Acute poisoning due to traditional medicines are not 
uncommon, yet estimates of mortality is 43% in South Africa (Stewart and 
Steenkamp, 2000). In Malaysia many cases of poisoning are not reported, hence the 
mortality rate could not be estimated (Thomsan, 2002 and  Popat et al., 2001).  Most 
of investigators carry out the in vivo toxicity assay in accordance to OECD 
(Organisation for Economic Co-operation and Development) guideline (Singh et al., 
2009; Mustaffa  et al., 2010a; Ridtitid et al., 2008 and Reanmongkol et al., 2007). 
The OECD guideline for testing up chemical was established by using internationally 
agreed testing methods used by government, industry and laboratories to assess the 
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safety of chemical products. It is required for all the animal based research to be 
carried out according to this guideline. Generally, acute toxicity assay is followed by 
histopathological analysis of various organs (Chen et al., 2007). All animals 
surviving to the end of the study and all animals dying during the period of 
observation will be subjected for autopsy and histopathological analysis. 
Histopathology analysis will be utilized as a useful tool for detection of organ 
damage or any adverse effects after the use of chemical substances.  
Table 2.3: Example of medicinal plants and their toxic effects 
Botanical name Traditional uses Toxic signs reported 
Acacia senegal Sexual diseases, 
haemorrhoids 
Diarrhoea, abdominal 
pains, vomiting 
Anogeissus leiocarpus Malaria, wound, 
constipation 
Salivation, nausea, 
vomiting 
Cassia alata Malaria, constipation Diarrhoea 
Cassia sieberiana Abdominal pains, malaria, 
jaundice, headache 
Diarrhoea, vomitting 
Entada africana Malaria, jaundice Vomiting 
Gardenia ternifolia Malaria, jaundice Diarrhoea, vomiting 
Optilia celtidifolia Malaria, abdominal pain, 
constipation 
Diarrhoea, trembling, 
vomiting 
Securidaca 
longepedonculata 
Haemorrhoids, dermatitis, 
snake bite, abdominal 
pains, headache 
Diarrhoea, vomiting 
 
 
 
Trichilia roka Haemorrhoids,fever, 
malaria, wounds 
Diarrhoea, vomitting 
                 (Maiga et al., 2005)  
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2.8 Analgesic 
2.8.1 Pharmaceutical Definition of Pain 
 Pain is defined as an unpleasant sensory and emotional experience caused by 
tissue damage. Pain is initiated by stimulation of nociceptors in the peripheral 
nervous system or central nervous system (Woolf and Mannion, 1999). Around one 
third of the world population suffer from pain. In the United States $100 billion was 
spent per year for the treatment of pains (Loeser, 2000). Medicinal plants are 
important sources of pharmacologically active compounds for the treatment of pains. 
Almost 80% of people living in developing countries depend on traditional medical 
practise as drug for therapeutic effects (Calixto, 2005). By definition, a drug is any 
natural or artificial substance that affects the process or function in the living 
organism (WHO, 1969). 
Pain can be stimulated by thermal, chemical or mechanical nociceptors. 
There are two basic forms of pain, acute and chronic. Chronic pain is due to mental 
and physical abnormalities and related to conditions such as back injury, migraine 
headaches, diabetic, neurophathy and cancer (Stucky et al., 2000). Physical effects 
include tense muscles, lack of energy and changes in appetite. Emotional effects 
include depression, anger and anxiety. Chronic pain persists for weeks, months or 
years (Shipton and Tait, 2005). In contrast, acute pain such as sprain and tissue injury 
lasts for only a few hours to a few days. Improper treatment of acute pain may lead 
to chronic pain (Hasford et al., 2004). According to the Malaysian Statistics on 
Medicine (2006), total opioid consumption for relief of chronic pain is 0.7268 
defined daily dose (DDD)/ 1000 population/day (Chye et al., 2008). This figure is 
very much lower than the opioid consumption in the Nordic countries which ranged 
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from 14.0 DDD/ 1000 population/day in Finland and 21.8 DDD/ 1000 
population/day in Sweeden (Nordic medico, 2004). 
There is no test or instrument to measure the intensity of pain specifically. 
However, instrument such as electromyography (EMG), magnetic resonance imaging 
(MRI) and X-rays can detect the cause of pain in muscle and tissues. A neurological 
examination is used to determine whether the nervous system is impaired (Oomen, 
2008). 
Drugs which result in relieving pains are categorized as analgesic drugs. 
Kaufman et al. (2000) reported that in the United States, the three most commonly 
used drugs were analgesic type of drugs which are acetaminophen, ibuprofen and 
aspirin. Analgesic drugs are classified as narcotic and non narcotic drugs. The non 
narcotic drugs are non steroidal anti-inflammatory drugs (NSAIDs) and paracetamol. 
Opioids are categorized as narcotic drugs.  
2.8.2 Non steroidal anti-inflammatory drugs (NSAIDs)  
NSAIDs have analgesic, antipyretic and anti-inflammatory actions. Examples 
of these drugs are aspirin, ibuprofen and naproxen (Stuart and Warden, 2010). 
NSAIDs are effective for the treatment of mild to severe pain including cancer and 
post surgical pain. The mechanism of analgesic action of NSAIDs is mediated 
peripherally via inhibition of cyclooxygenase (COX) enzyme (Burian and Geislinger, 
2005). COX enzyme catalyzes the conversion of arachidonic acid to prostaglandin 
(Figure 2.4). Prostaglandin modulates components of inflammation (bradykinin, 
histamine and substance P) as well as involvement in body temperature and pain 
transmission (Stringer, 2001). With the presence of NSAIDs the formation of COX 
  
21 
will be inhibited (Figure 2.4). Two isoforms of the COX enzyme have been 
identified which are COX-1 and COX-2.  COX-2 is expressed constitutively in brain 
and kidney and is induced at sites of inflammation. COX-1 is used for platelet 
formation and for the protection of the stomach. Inhibition of COX-1 will cause 
peptic ulcer as well as alteration of platelet function. Specific COX-2 inhibitors such 
as rofecoxib and celecoxib (NSAIDs) show anti-inflammatory activity without 
affecting COX-1 (Moore, 2009). NSAIDs are being metabolized by the liver and 
were proven to be more effective than paracetamol (Zhang and Po, 1998). Overdose 
of NSAIDs might cause gastrointestinal complication (Henry and Gettigan, 2003).  
 
 
 
 
 
 
 
 
     (Stringer, 2001) 
Figure 2.4: Pathway of NSAIDs action 
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2.8.3 Opioids 
By definition, an opioid is a chemical that works by binding to opioid 
receptors and used to treat moderate to severe pain. Opioids have actions at the 
central and peripheral nervous system. Examples of natural opioids are morphine and 
codeine (Moore, 2009). Synthetic opioids are pethidine and fentanyl (Hodgson et al., 
1999). Narcotic agents are potent analgesics which are effective for the relief of 
severe pain such as cancers. Within the central nervous system, opioids have effects 
in many areas including the cerebrum, medulla and spinal cord. The action of opioid 
in the peripheral nervous system is in the tissues such as joints, smooth muscle and 
gastro intestinal tract (Moore, 2009).  
The presynaptic inhibition by opioid is considered to be the major effect in 
the nervous system by preventing primary afferent fiber from releasing 
neurotransmitter. The mechanism of action for opioid is by binding to specific pain 
receptors in the central nervous system (CNS). Hence, it reduces the perception of 
pain (Stringer, 2001).  Three major types of opioid receptor include µ, δ and k (mu, 
delta and kappa). Once tissue injury happen, neuron releases signalling chemicals 
called neurotransmitter in the synapse. Synapse is the space between two neurons. 
Receptors are able to detect the neurotransmitter, hence perform an action of pain 
transmission (Ray and Ksir, 2002). One analogy that has been used to describe the 
interaction between the neurotransmitter and its receptor is that of lock and key, the 
neurotransmitter fits into a receptor as a key fits into a lock (Willis and Westlund, 
1997).  Some examples of neurotransmitter that is inhibited by psychoactive drugs 
are acetylcholine, norepinephrine, dopamine, serotonine, γ-aminobutyric acid 
(GABA) and the endorphins. Morphine, by an action on µ receptors, inhibits release 
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of several different neurotransmitters including noradrenaline, acetylcholine and the 
neuropeptide (substance P). The opioid antagonist, naloxone, inhibits all opioid 
receptors, but has highest affinity for µ receptors (Chahl, 1996). 
If the opioid drug is discontinued, withdrawal symptoms such as sweating, 
nausea and addiction are experienced by chronic users. Opioid addiction test carried 
out by Ghodse et al. (1999) reported that out of 127 opioid users, 103 (81.1%) 
developed addiction behaviour. Opioid also may cause several adverse effects such 
as pupillary constriction and constipation. Patients receiving chronic opioid therapy 
require continuous laxative therapy for the treatment of constipation (Ballantyne, 
2007).  
2.8.4 Paracetamol 
Acetaminophen or paracetamol is an antipyretic drug used to treat acute pain. 
It possesses anti-inflammatory action via the inhibition of cyclo-oxygenase enzyme 
in the central nervous system (Hinz et al., 2008).  Paracetamol does not work in 
peripheral nervous system due to the presence of peroxides during inflammation that 
inhibits the action of paracetamol. Overdose usage of paracetamol can lead to 
hepatotoxicity which can cause death (Larson, 2007). 
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Figure 2.5: Mechanism of opioid. Stimulus will cause primary afferent fiber to 
release neurotransmitter. Without the presence of the opioid, neurotransmitter will 
bind to the specific receptor and sent chemical message via the spinothalamic tracts 
at the spinal cord to the brain. In the brain, chemical messenger was interpreted as 
pain. With the presence of opioid, it binds at the specific opioid receptors and 
inhibits binding of neurotansmitter. Hence, pain transmission is blocked.   
2.9 Antimicrobial 
2.9.1 Antimicrobial Susceptibility Testing 
Antibiotics are substances produced by bacteria and fungi that inhibit the 
growth of other bacteria (Davey, 2000). The discovery of antibiotics that was once 
regarded as novel in the 20
th
 century is helpful in treating infectious diseases. 
Neurotransmitter 
released 
Neurotransmitter 
binds to receptor 
Pain 
Opioid inhibits the 
binding of the 
neurotransmitter to the 
receptors 
m 
Primary afferent fiber 
Spinothalamic 
tracts 
Brain 
Stimulus 
  
25 
However, microbial resistance to antibiotic had developed due to its indiscriminate 
use for the treatment of infectious diseases. So, scientist worldwide focused on 
discovery of new antimicrobial drugs from medicinal plants (Kumar et al., 2006). 
The screening of plants with potential antimicrobial activities against pathogenic 
microorganisms serves as the first step in discovery of antimicrobial drug. A variety 
of methods are found for the screening purposes such as bioautography, diffusion 
and dilution methods (Valgas et al., 2007).  The qualitative antimicrobial methods 
which indicate the presence or absence of antimicrobial activity or compounds are 
disc diffusion and bioautography.   
The disc diffusion method makes use of the filter Whatman, which is 
composed of cellulose [ß-(1-4) linked glucose monomer]. The bioautography method 
it employs the use of chromatograms and is a useful tool for identification of 
antibacterial compounds. However, incomplete removal of acidic or alkali solvents 
from TLC plate might interfere with the results by inhibiting the growth of bacteria 
(Hamburger and Cordell, 1987). Inhibition zones (white spots) on a purple-red 
background of TLC plates indicate conversion of p-iodonitrotetrazolium violet (INT) 
to coloured formazan did not occur due to the presence of antibacterial compound 
(Eloff and Masako, 2005).  
 The quantitative antimicrobial assay includes dilution method which 
determines the minimal inhibitory concentration (MIC) of test sample (Vanden and 
Vlientick, 1991).  The MIC values vary with the test organism, inoculums size, 
incubation time and aeration. The use of dye such as p-iodonitrotetrazolium violet 
(INT), triphenyl tetrazolium chloride (TTC) and methyl thiazolyl tetrazolium (MTT) 
serve as an indicator for microbial growth (Eloff, 1998).  The dye was used based on 
the fact that as the bacteria grow, it produces an electron which is transferred to the 
